168 related articles for article (PubMed ID: 16820177)
1. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
[TBL] [Abstract][Full Text] [Related]
2. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA.
Kindlundh-Högberg AM; Zhang X; Svenningsson P
Int J Neuropsychopharmacol; 2009 Mar; 12(2):201-15. PubMed ID: 18812013
[TBL] [Abstract][Full Text] [Related]
3. Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain.
Di Benedetto M; D'addario C; Candeletti S; Romualdi P
Neuroscience; 2006; 137(1):187-96. PubMed ID: 16289352
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
[TBL] [Abstract][Full Text] [Related]
5. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
6. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice.
Benturquia N; Courtin C; Noble F; Marie-Claire C
Brain Res; 2008 May; 1211():1-5. PubMed ID: 18433738
[TBL] [Abstract][Full Text] [Related]
7. Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain.
Kindlundh-Högberg AM; Schiöth HB; Svenningsson P
Neurotoxicology; 2007 Nov; 28(6):1158-69. PubMed ID: 17692920
[TBL] [Abstract][Full Text] [Related]
8. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.
Colussi-Mas J; Schenk S
Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603
[TBL] [Abstract][Full Text] [Related]
9. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
10. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
García-Osta A; Del Río J; Frechilla D
Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.
Armstrong BD; Noguchi KK
Neurotoxicology; 2004 Dec; 25(6):905-14. PubMed ID: 15474609
[TBL] [Abstract][Full Text] [Related]
13. Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy").
Brevard ME; Meyer JS; Harder JA; Ferris CF
Magn Reson Imaging; 2006 Jul; 24(6):707-14. PubMed ID: 16824965
[TBL] [Abstract][Full Text] [Related]
14. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
Adori C; Andó RD; Kovács GG; Bagdy G
J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Peterson AL; Gilman TL; Banks ML; Sprague JE
Synapse; 2006 Apr; 59(5):317-9. PubMed ID: 16421905
[TBL] [Abstract][Full Text] [Related]
16. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
[TBL] [Abstract][Full Text] [Related]
17. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
18. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
Piper BJ; Meyer JS
Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
[TBL] [Abstract][Full Text] [Related]
19. Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats.
Kindlundh-Högberg AM; Blomqvist A; Malki R; Schiöth HB
BMC Neurosci; 2008 Apr; 9():39. PubMed ID: 18419818
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
